CELZ - Company ID 0001187953
The table below shows CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $3.00K | $0.00 | $8.00K |
| Cost of revenue | $0.00 | $0.00 | $0.00 | $1.20K | $0.00 | $3.20K |
| Gross profit | $0.00 | $0.00 | $0.00 | $1.80K | $0.00 | $4.80K |
| R&D | $541.66K | $465.15K | $501.26K | $743.30K | $581.80K | $924.75K |
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. reported annual revenue of $6.00K for fiscal year 2025. That is down 45.5% from $11.00K in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A | $888.64K | $776.82K | $731.52K | $888.40K | $498.61K | $676.09K |
| Operating income | -$1.46M | -$1.27M | -$1.26M | -$1.66M | -$1.11M | -$1.63M |
| Income tax | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | -$1.41M | -$1.24M | -$1.23M | -$1.64M | -$1.04M | -$1.56M |
| EPS (diluted) | -$0.38 | -$0.48 | -$0.48 | -$0.83 | -$0.75 | -$1.11 |